Health
Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study – News-Medical.Net
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with…
Recent research indicates the occurrence of thromboembolic complications involving anti-phospholipid antibodies (APLA) and the anti-phospholipid syndrome (APS) in severe coronavirus disease 2019 (COVID-19). However, conflicting reports have emerged.
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with more severe COVID-19 symptoms and signs.
The team have released their findings as a preprint…
-
General21 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News8 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Noosa News23 hours agoPerth Royal Show attendance slumps to 10-year low
-
General20 hours agoAn open letter to pro-Palestinian protesters